Makary Resigns as FDA Commissioner Following Policy Disputes - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

  • By

  • Kathryn Wighton

  • May 12, 2026

  • 2 min

Share

Clinical Scorecard: Makary Resigns as FDA Commissioner Following Policy Disputes

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationGeneral public, healthcare providers, pharmaceutical companies, pediatric patients, pregnant women
Care Setting

Key Highlights

  • Marty Makary resigned after 13 months as FDA Commissioner, effective immediately.
  • His tenure included significant policy disputes and workforce reductions, particularly during the COVID-19 pandemic.

Guideline-Based Recommendations

Diagnosis

    Management

    • Focus on vaccine policy and dietary guidance initiatives, including stakeholder engagement.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        COVID-19 vaccine removed from CDC immunization schedule, impacting recommendations for healthy pediatric patients and pregnant women.

        Clinical Best Practices

        • Support federal efforts to phase out harmful food additives, referencing FDA guidelines.
        • Encourage reduced intake of highly processed foods, citing dietary recommendations.

        References

        Original Source(s)

        Makary Resigns as FDA Commissioner Following Policy Disputes

        • by Kathryn Wighton

        • May 12, 2026

        Related Content

        FDA adds generic valganciclovir oral solution

         The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.

        Depression, anxiety symptoms may be common in T1D

        National survey data show a greater mental health symptom burden among adults with type 1 diabetes vs. those with type 2 diabetes or no diabetes.

        Catheter stop orders may be losing ground

        A 20-year national survey reveals substantial gains in infection surveillance but inconsistent use of strategies to limit unnecessary urinary catheterization.